Glucuronidation is an important metabolic process of detoxification in all vertebrates. The reaction is catalyzed by a multigene family of UDP-glucuronosyltransferases (UGTs) able to convert many xenobiotics and endobiotics (hydrophobic substances) to inactive, water-soluble glucuronides. The UGTs play a protective role, facilitating the elimination of potentially toxic metabolites via urine, bile and feces; therefore, impairment of UGTs may have important toxicological consequences. The regulation of UGTs during bacterial infection or inflammation is not well described. In this study, we investigated the in vitro effect of lipopolysaccharide (LPS) on the expression of the UGT1A6 isoform in human colon carcinoma Caco-2 cells. Results demonstrated a significant down-regulation of UGT1A6 expression, both in terms of mRNA and protein levels, and a reduced UGT activity after LPS exposure of cell cultures, suggesting a role for endotoxins on UGT regulation mechanisms.
Meech R., Mackenzie PIStructure and function of uridine diphosphate glucuronosyltransferases. Clin Exp Pharmacol Physiol1997; 24: 907-915.
2.
Tephly T., Green M., Puig J., Irshaid Y.Endogenous substrates for UDP-glucuronosyltransferases. Xenobiotica1988; 18: 1201-1210.
3.
Tephly TR, Burchell B.UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends Pharmacol Sci1990; 11: 276-279.
4.
Mackenzie PI , Owens IS, Burchell B. et al. The UDP glycosyl-transferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics1997; 7: 255-269.
5.
Gregory PA, Lewinsky RH, Gardner-Stephen DA, Mackenzie PIRegulation of UDP glucuronosyltransferases in the gastrointestinal tract. Toxicol Appl Pharmacol2004; 199: 354-363.
6.
Mackenzie PIIdentification of uridine diphosphate glucuronosyltransferases involved in the metabolism and clearance of mycophenolic acid. Ther Drug Monit2000; 22: 10-13.
7.
Strassburg CP , Nguyen N., Manns MP, Tukey RHUDP-glucuronosyltransferase activity in human liver and colon. Gastroenterology1999; 116: 149-160.
8.
Strassburg CP , Nguyen N., Manns MP, Tukey RHPolymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol Pharmacol1998; 54: 647-654.
9.
Strassburg CP , Kneip S., Topp J. et al. Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine . Biol Chem2000; 275: 36164-36171.
10.
Strassburg CP, Oldhafer K., Manns MP, Tukey RHDifferential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol Pharmacol1997; 52: 212-220.
11.
Strassburg CP, Manns MP, Tukey RHExpression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem1998; 273: 8719-8726.
Bock-Hennig BS, Kohle C., Nill K., Bock KWInfluence of t-butylhydroquinone and beta-naphthoflavone on formation and transport of 4-methylumbelliferone glucuronide in Caco-2/TC-7 cell monolayers. Biochem Pharmacol2002; 63: 123-128.
14.
Münzel PA, Schmohl S., Buckle F. et al. Contribution of the Ah receptor to the phenolic antioxidant-mediated expression of human and rat UDP-glucuronosyltransferase UGT1A6 in Caco-2 and rat hepatoma 5L cells. Biochem Pharmacol2003; 66: 841-847.
15.
Ritter JK, Chen F., Sheen YY, Tran HM, Kimura S., Yeatman MT, Owens ISA novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem1992; 267: 3257-3261.
16.
Boman HGInnate immunity and the normal microflora. Immunol Rev2000; 173: 5-16.
17.
Rousset M.The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. Biochimie1986; 68: 1035-1040.
18.
Bradford MMA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem1976; 72: 248-254.
19.
Trubetskoy OV , Shaw PMA fluorescent assay amenable to measuring production of β-D-glucuronides produced from recombinant UDP-glycosyl transferase enzymes. Drug Metab Dispos1999 ; 27: 555-557.
20.
Ding AH, Nathan CF, Stuehr DJRelease of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol1988; 141: 2407-2412.
21.
Rousset M., Laburthe M., Pinto M. et al. Enterocytic differentiation and glucose utilization in the human colon tumor cell line Caco-2: modulation by forskolin. J Cell Physiol1985; 123: 377-385.
22.
Zweibaum A., Triadou N., Kedinger M. et al. Sucrase-isomaltase: a marker of foetal and malignant epithelial cells of the human colon. Int J Cancer1983 ; 32: 407-412.
23.
Sabolovic N., Magdalou J., Netter P., Abid A.Nonsteroidal antiinflammatory drugs and phenols glucuronidation in Caco-2 cells: identification of the UDP-glucuronosyltransferases UGT1A6, 1A3 and 2B7. Life Sci2000; 67: 185-196.
24.
Grancharov K., Engelberg H., Naydenova Z., Müller G., Rettenmeier AW, Golovinsky E.Inhibition of UDP-glucuronosyltransferases in rat liver microsomes by natural mutagens and carcinogens. Arch Toxicol2001; 75: 609-612.
25.
Mulder GJGlucuronidation and its role in regulation of biological activity of drugs . Annu Rev Pharmacol Toxicol1992; 32: 25-49.
26.
Ahotupa M., Mäntyla E.Comparison of the inducibilities of UDP-glucuronosyltransferase and polysubstrate monooxygenase activities in mice exposed to 20 model xenobiotics. Biochem Pharmacol1983; 32: 2612-2615.
27.
Castrén M., Oikari A.Changes of the liver UDP-glucuronosyltransferase activity in trout (Salmo gairdneri Rich.) acutely exposed to selected aquatic toxicants. Comp Biochem Physiol1987; 86: 357-360.
28.
Lawrence AJ , Michalkiewicz A., Morley JS, MacKinnon K., Billington D.Differential inhibition of hepatic morphine UDP-glucuronosyltransferases by metal ions. Biochem Pharmacol1992; 43: 2335-2340.
29.
Matsui M., Nagai F., Suzuki E., Okada M.Structure-activity relationships of nitrosamines and nitramines which stimulate UDP-glucuronosyltransferase activities in vitro. Biochem Pharmacol1984; 33: 2647-2651.
30.
Grancharov K., Naydenova Z., Lozeva S., Golovinsky E.Natural and synthetic inhibitors of UDP-glucuronosyltransferase . Pharmacol Ther2001; 89: 171-186.
31.
Mizuma T., Momota R., Haga M., Hayashi M.Factors affecting glucuronidation activity in Caco-2 cells. Drug Metab Pharmacokinet2004; 19: 130-134.
32.
Naganuma M. , Saruwatari A., Okamura S., Tamura H.Turmeric and curcumin modulate the conjugation of 1-naphthol in Caco-2 cells. Biol Pharm Bull2006; 29: 1476-1479.
33.
Verhagen H. , Schilderman PA, Kleinjans JCButylated hydroxyanisole in perspective. Chem Biol Interact1991; 80: 109-134.
34.
Schilderman PA, Verhagen H., Schutte B., Ten Hoor F., Kleinjans JCModulation by dietary factors of BHA-induced alterations in cell kinetics of gastro-intestinal tract tissues in rats. Food Chem Toxicol1991; 29: 79-85.
35.
Bishop A., Gallop PM, Karnovsky MLPyrroloquinoline quinone: a novel vitamin?Nutr Rev1998; 56: 287-293.
36.
Buetler TM, Gallagher EP, Wang C., Stahl DL, Hayes JD, Eaton DLInduction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol Appl Pharmacol1995; 135: 45-57.
37.
Ma Q., Kinneer K.Chemoprotection by phenolic antioxidants. Inhibition of tumor necrosis factor alpha induction in macrophages. J Biol Chem2002; 277: 2477-2484.
38.
Sherratt PJ , McLellan LI, Hayes JDPositive and negative regulation of prostaglandin E2 biosynthesis in human colorectal carcinoma cells by cancer chemopreventive agents. Biochem Pharmacol2003; 66: 51-61.
39.
Richardson TA, Sherman M., Kalman D., Morgan ETExpression of UDP-glucuronosyltransferase isoform mRNAs during inflammation and infection in mouse liver and kidney . Drug Metab Dispos2006; 34: 351-353.
40.
Heurtaux T. , Benani A., Moulin D., Muller N., Netter P., Minn A.Induction of UGT1A6 isoform by inflammatory conditions in rat astrocytes. Neuropharmacology2006; 50: 317-328.
41.
Monshouwer M., Witkamp RF, Nujmeijer SM, Van Amsterdam JG, Van Miert ASSuppression of cytochrome P450- and UDP glucuronosyl transferase-dependent enzyme activities by proinflammatory cytokines and possible role of nitric oxide in primary cultures of pig hepatocytes. Toxicol Appl Pharmacol1996; 137: 237-244.
42.
Henderson B. , Poole S., Wilson M.Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev1996; 60: 316-341.
43.
Bhattacharyya J., Biswas S., Datta AGMode of action of endotoxin: role of free radicals and antioxidants. Curr Med Chem2004 ; 11: 359-368.
